Two new graphics from Diabetes UK's COVID-19 task force address inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when intravenous equipment is unavailable.
from WebMD Health https://www.webmd.com/lung/news/20200505/more-guidance-on-inpatient-management-of-blood-glucose-in-covid-19?src=RSS_PUBLIC
0 Comments:
Post a Comment